![John Stuelpnagel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Stuelpnagel
Président chez
10X GENOMICS, INC.
Fortune : 70 M $ au 31/05/2026
Profil
John R. Stuelpnagel est un entrepreneur et un homme d'affaires qui a fondé Illumina, Inc., Fabric Genomics, Inc. et Ariosa Diagnostics, Inc. et qui a été à la tête de 6 sociétés différentes. Il est président de 10X Genomics, Inc. et de Fabric Genomics, Inc. et président d'Inscripta, Inc. et d'Element Biosciences, Inc. John R. Stuelpnagel est également membre du conseil d'administration de Federation Bio, Inc. et de Encoded Therapeutics, Inc. Dans le passé, le Dr Stuelpnagel a occupé les postes de directeur de l'exploitation et de directeur chez Illumina, Inc., d'associé chez CW Group, Inc. et de directeur des ressources humaines chez Sequenta, Inc. et de président exécutif d'Ariosa Diagnostics, Inc. Il est titulaire d'un doctorat et d'un diplôme de premier cycle de l'université de Californie, Davis, et d'un MBA de l'université de Californie, Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
10X GENOMICS INC 10,47 % | 31/03/2026 | 2 105 736 ( 10,47 % ) | 60 M $ | 31/05/2026 |
10X GENOMICS INC CLASS A 0,32 % | 04/06/2026 | 369 607 ( 0,32 % ) | 10 M $ | 31/05/2026 |
Postes actifs de John Stuelpnagel
| Sociétés | Poste | Début |
|---|---|---|
| 10X GENOMICS, INC. | Président | 01/08/2013 |
Fabric Genomics, Inc.
 Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Fondateur | - |
Inscripta, Inc.
 Inscripta, Inc. BiotechnologyHealth Technology Develops biomanufacturing solutions | Président | 01/04/2017 |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/05/2017 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Directeur/Membre du Conseil | 01/06/2020 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Consultant / Advisor | 01/01/1998 |
Anciens postes connus de John Stuelpnagel
| Sociétés | Poste | Fin |
|---|---|---|
Element Biosciences, Inc.
 Element Biosciences, Inc. BiotechnologyHealth Technology Develops DNA sequencing technology for the research and diagnostic markets | Président | 01/01/2023 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur/Membre du Conseil | 01/11/2017 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Fondateur | 01/01/2015 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de John Stuelpnagel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
10X Genomics, Inc.
 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Inscripta, Inc.
Inscripta, Inc. BiotechnologyHealth Technology Develops biomanufacturing solutions | Health Technology |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Health Technology |
Element Biosciences, Inc.
Element Biosciences, Inc. BiotechnologyHealth Technology Develops DNA sequencing technology for the research and diagnostic markets | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Commercial Services |
